Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Abdominal bloating: pathophysiology and treatment.

Seo AY, Kim N, Oh DH.

J Neurogastroenterol Motil. 2013 Oct;19(4):433-53. doi: 10.5056/jnm.2013.19.4.433. Epub 2013 Oct 7. Review.

2.

[Abdominal bloating: an up-to-date].

Ducrotté P.

Gastroenterol Clin Biol. 2009 Oct;33(10-11 Suppl):F94-100. doi: 10.1016/j.gcb.2009.08.004. Epub 2009 Sep 11. French.

3.

Abdominal bloating.

Azpiroz F, Malagelada JR.

Gastroenterology. 2005 Sep;129(3):1060-78. Review.

PMID:
16143143
4.

Bloating and functional gastro-intestinal disorders: where are we and where are we going?

Iovino P, Bucci C, Tremolaterra F, Santonicola A, Chiarioni G.

World J Gastroenterol. 2014 Oct 21;20(39):14407-19. doi: 10.3748/wjg.v20.i39.14407. Review.

5.

Review article: bloating in functional bowel disorders.

Zar S, Benson MJ, Kumar D.

Aliment Pharmacol Ther. 2002 Nov;16(11):1867-76. Review.

6.

Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders.

Houghton LA, Whorwell PJ.

Neurogastroenterol Motil. 2005 Aug;17(4):500-11. Review.

PMID:
16078938
8.

Management Strategies for Abdominal Bloating and Distension.

Foley A, Burgell R, Barrett JS, Gibson PR.

Gastroenterol Hepatol (N Y). 2014 Sep;10(9):561-71.

9.
10.

Review article: the treatment of functional abdominal bloating and distension.

Schmulson M, Chang L.

Aliment Pharmacol Ther. 2011 May;33(10):1071-86. doi: 10.1111/j.1365-2036.2011.04637.x. Epub 2011 Mar 29. Review.

11.

Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial.

Lacy BE, Schey R, Shiff SJ, Lavins BJ, Fox SM, Jia XD, Blakesley RE, Hao X, Cronin JA, Currie MG, Kurtz CB, Johnston JM, Lembo AJ.

PLoS One. 2015 Jul 29;10(7):e0134349. doi: 10.1371/journal.pone.0134349. eCollection 2015.

12.

A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence.

Sharara AI, Aoun E, Abdul-Baki H, Mounzer R, Sidani S, Elhajj I.

Am J Gastroenterol. 2006 Feb;101(2):326-33.

PMID:
16454838
13.

The pathogenesis of bloating and visible distension in irritable bowel syndrome.

Azpiroz F, Malagelada JR.

Gastroenterol Clin North Am. 2005 Jun;34(2):257-69. Review.

PMID:
15862934
14.

Profile of rifaximin and its potential in the treatment of irritable bowel syndrome.

Iorio N, Malik Z, Schey R.

Clin Exp Gastroenterol. 2015 Jun 8;8:159-67. doi: 10.2147/CEG.S67231. eCollection 2015. Review.

15.

Bloating and intestinal gas.

Jones MP.

Curr Treat Options Gastroenterol. 2005 Aug;8(4):311-8.

PMID:
16009032
16.

Pathophysiology, evaluation, and treatment of bloating: hope, hype, or hot air?

Lacy BE, Gabbard SL, Crowell MD.

Gastroenterol Hepatol (N Y). 2011 Nov;7(11):729-39.

17.

Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.

Kane JS, Ford AC.

Expert Rev Gastroenterol Hepatol. 2016;10(4):431-42. doi: 10.1586/17474124.2016.1140571. Epub 2016 Mar 1. Review.

PMID:
26753693
18.

Bloating and distention in irritable bowel syndrome: the role of visceral sensation.

Agrawal A, Houghton LA, Lea R, Morris J, Reilly B, Whorwell PJ.

Gastroenterology. 2008 Jun;134(7):1882-9. doi: 10.1053/j.gastro.2008.02.096. Epub 2008 Mar 8.

PMID:
18455167
19.

New and Emerging Treatment Options for Irritable Bowel Syndrome.

Lacy BE, Chey WD, Lembo AJ.

Gastroenterol Hepatol (N Y). 2015 Apr;11(4 Suppl 2):1-19.

20.

New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.

Foxx-Orenstein AE.

Therap Adv Gastroenterol. 2016 May;9(3):354-75. doi: 10.1177/1756283X16633050. Epub 2016 Feb 21. Review.

Supplemental Content

Support Center